A natural choice for hemophilia B
Authors: Dwight D, Koeberl;
pmid: 25745178
A natural choice for hemophilia B
Abstract
In this issue of Blood, Crudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that induced immune tolerance to factor IX (FIX) in a hemophilia B (HB) dog with previously formed anti-FIX inhibitor antibodies (IAs).
Related Organizations
- Duke University United States
Keywords
Factor IX, Male, Animals, Humans, Genetic Therapy, Hemophilia B
Factor IX, Male, Animals, Humans, Genetic Therapy, Hemophilia B
7 Research products, page 1 of 1
- 2014IsAmongTopNSimilarDocuments
- 2021IsAmongTopNSimilarDocuments
- 2019IsAmongTopNSimilarDocuments
- 2016IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
popularity
Popularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
0
Average
Average
Average
bronze
